| Name | No. | For Patients with | Purpose |
|---|---|---|---|
| CLL17 | 20-22 | Previously untreated Chronic Lymphocytic Leukaemia (CLL) |
This trial will compare the efficacy of continuous ibrutinib monotherapy with fixed-duration venetoclax plus obinutuzumab and fixed-duration ibrutinib plus venetoclax in patients with previously untreated CLL |
